AURKAPS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.966649065821E-12 |
Normal-vs-Stage2 |
4.11839999999719E-05 |
Normal-vs-Stage3 |
2.88360000322285E-08 |
Normal-vs-Stage4 |
8.67230000034525E-08 |
Stage1-vs-Stage2 |
3.728600E-01 |
Stage1-vs-Stage3 |
2.907200E-01 |
Stage1-vs-Stage4 |
9.365500E-02 |
Stage2-vs-Stage3 |
9.388000E-01 |
Stage2-vs-Stage4 |
6.250000E-01 |
Stage3-vs-Stage4 |
5.053400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
7.70960000000542E-05 |
Normal-vs-Asian |
6.21300000003266E-07 |
Caucasian-vs-AfricanAmerican |
6.482200E-01 |
Caucasian-vs-Asian |
5.601400E-01 |
AfricanAmerican-vs-Asian |
3.920200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.2859492077032E-12 |
Normal-vs-Female |
1.62647673107585E-12 |
Male-vs-Female |
4.666000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.041000E-03 |
Normal-vs-Age(41-60Yrs) |
6.61803944979056E-13 |
Normal-vs-Age(61-80Yrs) |
7.92810261884824E-13 |
Normal-vs-Age(81-100Yrs) |
3.057700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.034000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.723200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.898800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.797600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.787400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.822400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.095790E-02 |
Normal-vs-Grade 2 |
2.26751950549442E-12 |
Normal-vs-Grade 3 |
3.96539467928392E-11 |
Normal-vs-Grade 4 |
6.7469999998071E-07 |
Grade 1-vs-Grade 2 |
6.124000E-01 |
Grade 1-vs-Grade 3 |
4.034400E-01 |
Grade 1-vs-Grade 4 |
5.648200E-01 |
Grade 2-vs-Grade 3 |
4.493400E-01 |
Grade 2-vs-Grade 4 |
9.236200E-01 |
Grade 3-vs-Grade 4 |
6.376800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.93431945408429E-13 |
Normal-vs-ccB subtype |
2.12699999835309E-08 |
ccA subtype-vs-ccB subtype |
3.093600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.92454949146759E-12 |
Normal-vs-N1 |
1.156020E-03 |
N0-vs-N1 |
2.865000E-01 |
|
|